Brentuximab Vedotin with Adriamycin, Vinblastine and Dacarbazine for Patients Aged 18-59 Years with Untreated Advanced-stage Classical Hodgkin Lymphoma: a Real-life Experience
CompletedOBSERVATIONAL
Enrollment
200
Participants
Timeline
Start Date
January 1, 2013
Primary Completion Date
January 30, 2025
Study Completion Date
January 30, 2025
Conditions
Classic Hodgkin LymphomaAdvanced Hodgkin Lymphoma
Trial Locations (1)
80131
Federico II University,, Naples
All Listed Sponsors
lead
Federico II University
OTHER
NCT06857500 - Brentuximab Vedotin with Adriamycin, Vinblastine and Dacarbazine for Patients Aged 18-59 Years with Untreated Advanced-stage Classical Hodgkin Lymphoma: a Real-life Experience | Biotech Hunter | Biotech Hunter